Skip to main content

Anika Therapeutics(ANIK-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Anika Reports Second Quarter Fiscal 2022 Financial Results

Globe Newswire - Wed Aug 3, 2022

Second quarter revenue growth up 4%
X-Twist510(k) clearance received; Limited market release on schedule for 2H 2022

BEDFORD, Mass., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today reported financial results for its second quarter ended June 30, 2022.

Read more at globenewswire.com

Provided Content: Content provided by Globe Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.

More from The Globe